Turning Tragedy into Action – A Family’s Fight for Genetic Awareness

  Dr. Matt Goldstein, the CEO of jScreen, that focuses on providing accessible, life-saving genetic testing to empower individuals with critical health insights joins eHealth Radio and the Cancer Prevention and Health News Channels. Listen to interview with host Eric Michaels & guest Dr. Matt Goldstein discuss the following:

1. Tell me about your role at jScreen and your background.
2. How did you come to join jScreen and tell us about the public initiative and what they do?
3. What is the most important thing people need to know about genetic testing when planning a family?
4. Jscreen also offers genetic cancer testing – can you tell us about this?
5. Where can people go to learn more about jScreen and get tested?

Summary: Genetic and Cancer genetic testing can save lives and the more people that do get tested the more lives can be saved.  To learn more visit https://www.jscreen.org. Dr. Matt Goldstein is a dedicated physician-scientist and entrepreneur with a passion for advancing genetic research. As CEO of jScreen, he focuses on providing accessible, life-saving genetic testing to empower individuals with critical health insights. With extensive experience in biotech, Dr. Goldstein has led major initiatives, including founding and guiding companies like Tango Therapeutics and Neon Therapeutics through pivotal clinical developments and strategic partnerships. A graduate of Stanford University's MD/PhD program, he completed his clinical training at Harvard Medical School. Driven by both professional and personal experiences, including the loss of his eldest daughter, Havi, to Tay-Sachs disease, Dr. Goldstein is deeply committed to jScreen's mission of proactive health management. Website: https://www.jscreen.org Social Media Links: X: https://x.com/myjscreen Instagram: https://www.instagram.com/getjscreened Linkedin: https://www.linkedin.com/company/jscreen People also listened to this: Empowering Women to Navigate Perimenopause with Confidence